OTEZLA
Live / Registered — Registered and renewed (as of 01 Nov 2023)
What this means for you
Registered since 07 May 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 May 2033: the §8 & §9 renewal).
Record
- Serial number
- 85705380
- Registration number
- 4331247
- Mark type
- Word mark
- Filed
- 16 Aug 2012
- Published for opposition
- 19 Feb 2013
- Registered
- 07 May 2013
- Current term from
- 07 May 2023
- Next maintenance filing
- §8 & §9 renewal, due by 07 May 2033 (grace period to 07 Nov 2033)
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
Owner
- AMGEN INC., Thousand Oaks, CA, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Nov 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 Nov 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 May 2023 — TEAS SECTION 8 & 9 RECEIVED
- 07 May 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Jun 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 27 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 May 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS